Loss of Shp2 Phosphatase Favors Alternative Activation of Macrophages, Contributing to Pulmonary Fibrosis in Mice

Bo Tao,Xue Zhang,Wei Jin,Yun Zhang,Hong Qiang Cheneg,Yue Hai Ke

DOI: https://doi.org/10.1096/fasebj.27.1_supplement.835.7

2013-01-01

Abstract:Alternative activation of macrophages (M2) in lungs has been implicated as driving pulmonary fibrosis. However, the mechanisms underlying M2 polarization are largely uncharacterized. Shp2, a ubiquitously expressed cytoplasmic tyrosine phosphatase, has previously been shown to be a critical signal transducer in various inflammatory diseases. In this report, we found that inactivation of Shp2 phosphatase augments IL‐4‐mediated M2 polarization in vitro, suggesting a potential negative regulation for this enzyme. To further unveil physiological roles of Shp2 in M2, we generated macrophage‐specific Shp2‐knockout mice under the control of LysM‐Cre promoter (Shp2flox/flox, Lysm‐Cre), Shp2‐deficient mice exhibit a marked shift of polarized balance in favor of IL‐4 mediated alternative activation. Additionally, there was a notable increase in arginase 1 activity when chitin was intraperitoneally administered to Shp2‐deficient mice. Moreover, these mice appeared to be more sensitive to bleomycin‐induced inflammation and pulmonary fibrosis. Mechanistically, Shp2 associates with IL‐4R¦Á and inhibits downstream JAK1‐STAT6 signaling by its catalytic domain in Shp2‐deficient mice, contributing to the observed phenotypic changes. Together, these findings identify Shp2 as a novel regulator of alveolar macrophage activation, and indicate that deregulation of Shp2 results in pulmonary fibrosis.